Ultragenyx Pharmaceutical Inc. Stock Performance

Open $15.29	Prev. Close $15.29	Circuit Range N/A
Day Range $15.29 - $15.73	Year Range $12.73 - $39.38	Volume 1,42,395
Average Traded $15.51

Ultragenyx Pharmaceutical Inc. Share Price Today

As of 11 October 2026, Ultragenyx Pharmaceutical Inc.'s share price is $15.49. The stock opened at $15.29, compared to its previous close of $15.29. During today's trading session, Ultragenyx Pharmaceutical Inc.'s share price traded between $15.29 and $15.73, with an average price of $15.51. Over the past 52 weeks, the stock has recorded a high of $39.38 and a low of $12.73. In terms of performance, Ultragenyx Pharmaceutical Inc.'s share price has declined by 37.25% over the last six months and is down 55.15% on a year-on-year basis.

Ultragenyx Pharmaceutical Inc. Share Price Chart

$15.29$15.73

Ultragenyx Pharmaceutical Inc. Stock Fundamentals & Key Indicators

Market Cap $1.53B	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-5.94	Revenue (TTM) $673.00B	Return On Equity (TTM) 201.36%
Profit Margin -85.44%	Debt to Equity 0.00	Quarterly Earnings Growth YoY 49.01%

Ultragenyx Pharmaceutical Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$159.93	$207.28	$136.00	$214.00
Net Profit	-$180.41	-$128.56	-$185.00	-$92.00
Net Profit Margin	-112.81%	-62.02%	-136.03%	-42.99%
Income Change	N/A	28.74%	-43.90%	50.27%

Ultragenyx Pharmaceutical Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$363.33	$434.00	$560.00	$673.00
Net Profit	-$707.42	-$607.00	-$569.00	-$575.00
Net Profit Margin	-194.70%	-139.86%	-101.61%	-85.44%
Income Change	N/A	14.20%	6.26%	-1.05%

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Ultragenyx Pharmaceutical Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$14.96	$15.53	+3.22%
Sep 2026	$25.37	$15.04	-42.73%
Aug 2026	$24.68	$26.27	+5.54%
Jul 2026	$33.31	$24.89	-25.47%
Jun 2026	$23.52	$33.40	+39.58%
May 2026	$24.97	$23.93	-3.08%
Apr 2026	$21.02	$24.68	+18.00%
Mar 2026	$22.52	$20.92	-10.52%
Feb 2026	$23.95	$23.38	-2.75%
Jan 2026	$22.89	$24.04	+4.50%
Dec 2025	$33.96	$23.00	-33.84%
Nov 2025	$34.20	$34.77	+0.67%

RARE Share Price FAQs

What is Ultragenyx Pharmaceutical Inc. share price today?

Ultragenyx Pharmaceutical Inc. share price today is $15.49 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Ultragenyx Pharmaceutical Inc. stock?

The 52 week high of Ultragenyx Pharmaceutical Inc. stock is $39.38, while the 52 week low is $12.73 as of 10 Oct '26.

What is RARE's market capitalisation today?

RARE market capitalisation is $1.53B as of October 11, 2026, at 4:15 am IST.

What is RARE's net income for the last quarter?

RARE's net income for the last quarter is -92.00B USD.

What is the 5 year returns of RARE?

The 5 year returns of RARE is -81.54% as on 10 Oct '26.

What is the high & low stock price of RARE today?

RARE stock price hit a high of $15.73 and low of $15.29 as of 10 Oct '26.

Can I buy RARE shares in India?

Yes. You can buy RARE in India by opening an international trading account.